Graf, T., Thiele, T., Klingebiel, R., Greinacher, A., Schäbitz, W., & Greeve, I. (2021). Immediate high-dose intravenous immunoglobulins followed by direct thrombin-inhibitor treatment is crucial for survival in Sars-Covid-19-adenoviral vector vaccine-induced immune thrombotic thrombocytopenia VITT with cerebral sinus venous and portal vein thrombosis. J Neurol.

Graf, Tilmann, Thomas Thiele, Randolf Klingebiel, Andreas Greinacher, Wolf-Rüdiger Schäbitz, and Isabell Greeve. "Immediate High-dose Intravenous Immunoglobulins Followed By Direct Thrombin-inhibitor Treatment Is Crucial for Survival in Sars-Covid-19-adenoviral Vector Vaccine-induced Immune Thrombotic Thrombocytopenia VITT With Cerebral Sinus Venous and Portal Vein Thrombosis." J Neurol 2021.

Graf, Tilmann, et al. "Immediate High-dose Intravenous Immunoglobulins Followed By Direct Thrombin-inhibitor Treatment Is Crucial for Survival in Sars-Covid-19-adenoviral Vector Vaccine-induced Immune Thrombotic Thrombocytopenia VITT With Cerebral Sinus Venous and Portal Vein Thrombosis." J Neurol 2021.